The difference in atherogenic properties of intramyocardial coronary arteries (ICA) and epicardial coronary arteries (ECA)…

The glorious city of Barcelona, Spain was resplendent in the summer sun this August, as cardiologists from all over the world flocked to take part in the…

Catheter ablation (CA) with the use of fluoroscopy became a gold standard of treatment for recurring regular supraventricular tachycardias…

Cardiac disease often impacts cancer therapy, from direct toxicity of cancer therapeutic agents to the coronary endothelium, the myocardium, heart valves…

Second-generation drug-eluting stents are currently considered the standard of care in patients undergoing treatment for coronary artery disease…

The prevalence of atrial fibrillation (AF) increases every year; some scientists project that between 2010 and 2060 the number of…

Ischaemic mitral prolapse (IMP) is a pathologic entity encountered in about one-third of patients undergoing surgery for ischaemic mitral regurgitation.

The detrimental effect of severe mitral regurgitation (MR) on morbidity and mortality is well established.1 In patients with MR…

Cardiac diseases have complex molecular origins. However, current clinical diagnostic tools are often inadequate to uncover specific molecular components…